Medtronic's newest insulin pump improves blood sugar control in children with diabetes: study

The 780G pump is designed to work with Medtronic’s Guardian sensors to continuously monitor glucose levels throughout the day and automatically adjust insulin dosage every five minutes as needed. It received CE mark clearance in Europe in 2020 and is currently undergoing FDA review in the U.S.

In the study, more than 3,200 European patients aged 15 and younger used the 780G system in tandem with the Guardian Sensor 3 to manage their Type 1 diabetes. After one year, their average time in range—indicating the percentage of the day spent within target blood sugar limits—closely mirrored that of adult diabetes patients.